The Oncology Institute to Participate at the Credit Suisse 31st Annual Healthcare Conference
The Oncology Institute to Participate at the Credit Suisse 31st Annual Healthcare Conference
CERRITOS, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that its Chief Executive Officer, Brad Hively, and its Chief Financial Officer, Mihir Shah, will participate in the Credit Suisse 31st Annual Healthcare Conference in Rancho Palos Verdes on Thursday, November 10.
全球通讯社加利福尼亚州塞里托斯2022年11月1日电美国最大的基于价值的肿瘤学组织之一肿瘤研究所公司(纳斯达克：TOI)今天宣布，其首席执行官布拉德·海弗利和首席财务官米希尔·沙阿将参加11月10日(星期四)在帕洛斯维尔德斯举行的瑞士信贷第31届年度医疗大会。
About The Oncology Institute, Inc.
肿瘤学研究所简介
Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.7 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 90+ employed clinicians and more than 700 teammates in over 50 clinic locations and growing, TOI is changing oncology for the better. For more information visit .
TOI成立于2007年，通过在社区环境中提供高度专业化的、基于价值的癌症护理来推动肿瘤学的发展。TOI为大约170万患者提供基于证据的尖端癌症护理，包括临床试验、输血和其他传统上与最先进的护理提供机构相关的护理提供模式。TOI拥有90多名受雇的临床医生和50多个诊所的700多名队友，而且还在不断增长，TOI正在让肿瘤学变得更好。有关更多信息，请访问。
Contacts
联系人
Media
媒体
The Oncology Institute
Julie Korinke
juliekorinke@theoncologyinstitute.com(562) 735-3226 x 88806
肿瘤学研究所
朱莉·科林克
电子邮件：juliekorinke@theoncologyInstitute te.com
Juan Lezama
juanlezama@theoncologyinstitute.com(562) 374-8434
胡安·莱扎马
邮箱：juanlezama@theoncologyInstitute te.com(562)374-8434
Investors
投资者
Solebury Trout
Maria Lycouris
investors@theoncologyinstitute.com
索尔伯里鲑鱼
玛丽亚·吕库利斯
邮箱：Investors@theoncologyInstitute te.com